Amol Jashvant Shah

Amol Jashvant Shah

Active Director Designated Partner DIN 00171006
DIN 00171006 First appointment May 1986 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 12 active board seats
Past companies 10 historical roles
Total affiliations 22 Since May 1986
Shareholding value Locked Premium profile
Directorship timeline
First appointment 29 May 1986
Active appointments 19
Total timeline records 22

Appointment history

Since 1986
Eris M. J. Biopharm Private Limited Director · 2022 - 2026
Current
Fine Aroma Specialities Private Limited Director · 2020 - 2026
Current
Current
Camlin Fine Sciences Limited Director · 2019 - 2026
Current
M. J. Biopharm Private Limited Managing Director · 2019 - 2026
Current
Current
Organic Biosystems Llp Designated Partner · 2017 - 2026
Current
Anglo Gulf Llp Designated Partner · 2015 - 2026
Current
Mj Medical Devices Private Limited Director · 2014 - 2026
Current
Current
Innova Life Sciences Private Limited Director · 2003 - 2026
Current
Fine Fragrances Private Limited Director · 2000 - 2026
Current
Marvel Life Sciences Private Limited Director · 2000 - 2026
Current
Aptek Computers Private Limited Director · 1998 - 2026
Current
M J Holdings And Leasing Ltd Director · 1998 - 2026
Current
M J Biopharm Private Limited Managing Director · 1997 - 2026
Current
Aptek Electronics Private Limited Director · 1992 - 2026
Current
M J Exports Private Limited Director · 1989 - 2026
Current
Marvel Chemicals Private Limited Director · 1986 - 2026
Current
Health On Demand Private Limited Director · 2016 - 2019
Previous
Bdr Lifesciences Private Limited Director · 2000 - 2010
Previous
Previous

Interactive timeline

Hover bars for tenure details
Loading chart...
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available